The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Brightgene Bio-medical Technology Co's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Brightgene Bio-medical Technology Co's Dividend Payout Ratio or its related term are showing as below:
SHSE:688166'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15 Med: 0.23 Max: 1.6
Current: 0.57
During the past 10 years, the highest Dividend Payout Ratio of Brightgene Bio-medical Technology Co was 1.60. The lowest was 0.15. And the median was 0.23.
SHSE:688166's Dividend Payout Ratio is ranked worse than 61.65% of 133
companies
in the Biotechnology industry
Industry Median: 0.44
vs SHSE:688166: 0.57
During the past 10 years, the highest Trailing Annual Dividend Yield of Brightgene Bio-medical Technology Co was 0.66%. The lowest was 0.05%. And the median was 0.29%.
During the past 3 years, the average Dividends Per Share Growth Rate was -7.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 3.30% per year.
During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Brightgene Bio-medical Technology Co was 11.60% per year. The lowest was -7.20% per year. And the median was 4.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Brightgene Bio-medical Technology Co (SHSE:688166) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Brightgene Bio-medical Technology Co Dividend Payout Ratio Related Terms
Brightgene Bio-medical Technology Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Brightgene Bio-medical Technology Co Dividend Payout Ratio Chart
SHSE:688166 vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison
For the Biotechnology subindustry, Brightgene Bio-medical Technology Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Brightgene Bio-medical Technology Co Dividend Payout Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Brightgene Bio-medical Technology Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Brightgene Bio-medical Technology Co's Dividend Payout Ratio falls into.
Brightgene Bio-medical Technology Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Brightgene Bio-medical Technology Co (SHSE:688166) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Brightgene Bio-medical Technology Co and its competitors. Over the past decade, Brightgene Bio-medical Technology Co's Dividend Payout Ratio has ranged from 0.15 to 1.60. According to the industry distribution chart, Brightgene Bio-medical Technology Co ranks #82 out of 133 companies in the Biotechnology industry, placing it in the top 61.7%.
Is Brightgene Bio-medical Technology Co's Dividend Payout Ratio too high?
Brightgene Bio-medical Technology Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 1.60. Based on the distribution chart, Brightgene Bio-medical Technology Co ranks #82 out of 133 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Brightgene Bio-medical Technology Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Brightgene Bio-medical Technology Co's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Brightgene Bio-medical Technology Co ranks #82 out of 133 companies for Dividend Payout Ratio. This places Brightgene Bio-medical Technology Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.44. Historically, Brightgene Bio-medical Technology Co's own Dividend Payout Ratio has ranged from 0.15 to 1.60 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.44, based on 133 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Brightgene Bio-medical Technology Co and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Brightgene Bio-medical Technology Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brightgene Bio-medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co (SHSE:688166) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥38.49, compared to a current price of ¥31.19 — trading 19% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Brightgene Bio-medical Technology Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Brightgene Bio-medical Technology Co (SHSE:688166), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Brightgene Bio-medical Technology Co (SHSE:688166) Overvalued in 2026?
Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co stock appears to be undervalued.
The current stock price of ¥31.19 is trading 19% below its estimated GF Value™ of ¥38.49.
GuruFocus considers Brightgene Bio-medical Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688166:
Dividend Payout Ratio: 0.00
GF Value™: ¥38.49 vs. price of ¥31.19 (19% below fair value)
No single metric tells the full story. See the SHSE:688166 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Brightgene Bio-medical Technology Co Business Description
Brightgene Bio-medical Technology Co Ltd is engaged in the Research and development and production of pharmaceutical intermediates, active pharmaceutical ingredients and formulations with high technological barriers.
84GF Score
Get the complete analysis for SHSE:688166
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688166 has been successfully added to your 
